Petteri Hervonen

Adrenal gland cancer Anal cancer Appendix cancer Bile duct cancer Bone sarcoma Brain cancer Breast cancer Central nervous system tumors Cervical cancer Colonic and rectal cancer Endometrial cancer and uterine sarcomas Gastrointestinal stromal tumor (GIST) Gastrointestinal tract cancer and pancreatic cancer Kidney cancer Laryngeal cancer Lip cancer Liver cancer Lung cancer Mediastinal tumors Melanoma Mesothelioma Nasopharyngeal cancer Neuroendocrine tumors Ocular and orbital cancer Oesophageal and cardial cancer Oral cavity cancer Oropharyngeal and hypopharyngeal cancer Ovarian and fallopian tube cancer Pancreatic cancer Parathyroid cancer Pituitary gland tumors Prostate cancer Salivary gland cancer Skin cancer Soft tissue sarcomas Stomach cancer Testicular cancer Thyroid cancer Trophoblastic diseases Urinary bladder cancer Vaginal cancer Vulval cancer


Petteri Hervonen


July 12, 1970, Helsinki, Finland


M.D., Ph.D.
Specialist in Medical Oncology




Matricular examination 1989
Good Clinical Practice (GCP) test 2009 (Roche oy Finland)
Participation in numerous clinical trials including: PROSTY and
PROSTY II, AdRad and AdPro prostate cancer trials


  • M.D. University of Tampere, 1996
  • Specialist in Oncology, Board Certificate Radiotherapy and Oncology, University of Tampere 2002
  • Consultant in Radiotherapy and Medical Oncology, Tampere University
  • Hospital, Department of Oncology 1/2002-12.11.2006, 01.08.2010-
  • Senior Lecturer, Tampere University Medical School 2004- 12.11.2006, 01.08.2010-
  • Medical Advisor, Head of Medical Managers, Roche Oy 13.11.2006-31.07.2010

Language proficiency:

Native language Finnish
Certificate of proficiency in English and Swedish, University of Tampere
English language excellent


Show more Show less